Joost J Jacobus Breeksema (Joost J Breeksema)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Combination Therapy

Molecularly Imprinted

Autism Spectrum Disorder

Top Venues

Scientific reports

Journal of psychopharmacology (Oxford, England)

ACS pharmacology & translational science

Psychopharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Joost J Jacobus Breeksema, Alistair Niemeijer, Erwin Krediet, Tilman Karsten, Jeanine Kamphuis, Eric H G J M Vermetten, Wim van den Brink, Robert A Schoevers
Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study. Scientific reports 14 (1) (2024)
Joost J Jacobus Breeksema, Alistair Niemeijer, Erwin Krediet, Tilman Karsten, Jeanine Kamphuis, Eric H G J M Vermetten, Wim van den Brink, Robert A Schoevers
Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study. Scientific reports 14 (1) (2024)
Joost J Jacobus Breeksema, Alistair Niemeijer, Erwin Krediet, Tilman Karsten, Jeanine Kamphuis, Eric H G J M Vermetten, Wim van den Brink, Robert A Schoevers
Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study. Scientific reports 14 (1) (2024)
Joost J Jacobus Breeksema, Alistair Niemeijer, Bouwe Kuin, Jolien Veraart, Eric Vermetten, Jeanine Kamphuis, Wim van den Brink, Robert Schoevers
Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study. Psychopharmacology (2023)
Joost J Jacobus Breeksema, Bouwe W Kuin, Jeanine Kamphuis, Wim van den Brink, Eric H G J M Vermetten, Robert A Schoevers
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. Journal of psychopharmacology (Oxford, England) 36 (10) (2022)
Joost J Jacobus Breeksema, Michiel van Elk
Working with Weirdness: A Response to "Moving Past Mysticism in Psychedelic Science". ACS pharmacology & translational science 4 (4) (2021)
Jan G C van Amsterdam, Gjalt-Jorn Ygram Peters, Ed Pennings, Tom Blickman, Kaj Hollemans, Joost J Jacobus Breeksema, Johannes G Ramaekers, Cees Maris, Floor van Bakkum, Ton Nabben, Willem Scholten, Tjibbe Reitsma, Judith Noijen, Raoul Koning, Wim van den Brink
Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis. Journal of psychopharmacology (Oxford, England) 35 (5) (2021)